Dr Jones noted that in response to the risk of AIDS in the early 80's, the Newcastle Centre took the following action: cryoprecipitate was reserved for children, factor concentrates continued to be used and non urgent surgery was put off. Read more about Dr Jones noted that in response to the risk of AIDS in the early 80's, the Newcastle Centre took the following action: cryoprecipitate was reserved for children, factor concentrates continued to be used and non urgent surgery was put off.
Dr Jones decided that despite some risk regarding Factor concentrate at the time, the switch to cryoprecipitate was not made. Read more about Dr Jones decided that despite some risk regarding Factor concentrate at the time, the switch to cryoprecipitate was not made.
Dr Hamilton, on behalf of Dr Jones attended a meeting at a Heathrow Airport hotel where AIDS was discussed, however Dr Jones does not recall discussing the meeting or taking specific action as a result of this meeting. Read more about Dr Hamilton, on behalf of Dr Jones attended a meeting at a Heathrow Airport hotel where AIDS was discussed, however Dr Jones does not recall discussing the meeting or taking specific action as a result of this meeting.
Dr Jones in his statement to the Inquiry noted that he increased testing and surveillance at the Newcastle Centre when the risk of AIDS for people with haemophilia was brought to his attention. Read more about Dr Jones in his statement to the Inquiry noted that he increased testing and surveillance at the Newcastle Centre when the risk of AIDS for people with haemophilia was brought to his attention.
Dr Jones stated that clinicians were only reliant on commercial concentrates because there was insufficient NHS product. Read more about Dr Jones stated that clinicians were only reliant on commercial concentrates because there was insufficient NHS product.
Dr Jones stated that if NHS concentrates had been manufactured to the same general standards of the commercial concentrates, they would have been used exclusively for home therapy in the UK. Read more about Dr Jones stated that if NHS concentrates had been manufactured to the same general standards of the commercial concentrates, they would have been used exclusively for home therapy in the UK.
Dr Jones in his statement to the Inquiry could not explain the discrepancy in the age range for cryoprecipitate but it was trying to cover the youngest children. Read more about Dr Jones in his statement to the Inquiry could not explain the discrepancy in the age range for cryoprecipitate but it was trying to cover the youngest children.
Dr Jones stated in a publication 'AIDS and the Blood' that it was best practice to treat children under 4 with cryoprecipitate. Read more about Dr Jones stated in a publication 'AIDS and the Blood' that it was best practice to treat children under 4 with cryoprecipitate.
It was noted in a report on the optimum use of Factor VIII preparations that at the Newcastle Haemophilia Centre cryoprecipitate would be used to treat bleeds in most circumstances and it was also used for surgery and dental extraction, whilst Hemofil was used for home therapy and for severe bleeds. Read more about It was noted in a report on the optimum use of Factor VIII preparations that at the Newcastle Haemophilia Centre cryoprecipitate would be used to treat bleeds in most circumstances and it was also used for surgery and dental extraction, whilst Hemofil was used for home therapy and for severe bleeds.
Dr Jones championed the use of cryoprecipitate in haemophiliacs as early as 1972, as per his article "Answering the needs of haemophilic children and their families Community Medicine" Read more about Dr Jones championed the use of cryoprecipitate in haemophiliacs as early as 1972, as per his article "Answering the needs of haemophilic children and their families Community Medicine"